Last reviewed · How we verify
NCT06816758
Evaluation of Diagnosis and Treatment Methods in Corrosive Esophagitis: A 26-Year Experience-Based Algorithm
trial testing Routine Care for Corrosive Esophagitis in Esophageal Diseases in 501 participants. Completed in 15 May 2025.
10 May 2025
Quick facts
| Lead sponsor | Caner İşevi, MD |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 501 |
| Start date | 1 May 2025 |
| Primary completion | 10 May 2025 |
| Estimated completion | 15 May 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Routine Care for Corrosive Esophagitis
Conditions studied
- Esophageal Diseases — all drugs for Esophageal Diseases →
Sponsor
Caner İşevi, MD
Who can join
18 and older, any sex, with Esophageal Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the diagnosis and treatment methods for corrosive esophagitis based on 26 years of clinical experience. It will retrospectively analyze patient records to identify patterns in clinical outcomes, complications, and the effectiveness of treatment strategies. The study focuses on optimizing patient care by proposing a diagnosis and treatment algorithm that can guide future clinical practices. Data will be collected from hospital archives and electronic health records, covering cases of corrosive esophagitis managed at Ondokuz Mayıs University between 1998 and 2024.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06816758
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Esophageal Diseases
Currently open trials in the same condition.
- NCT06721520 — Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy · Phase 2, PHASE3 · recruiting
- NCT06835374 — Comparative Assessment of Esophagitis in Cases With and Without Esophageal Motility Disorders: A Prospective Study · NA · recruiting
- NCT06870630 — Standard Versus Oesophago-gastric Junction Complex Myotomy for Treatment naïve Type 2 Achalasia Patients · NA · recruiting
- NCT05624099 — Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. · Phase 2 · recruiting
- NCT06514079 — Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children · NA · recruiting
Other Caner İşevi, MD trials
Trials by the same sponsor.
- NCT07238582 — Effectiveness of an Innovative Chest Stabilizer in Rib Fracture Treatment: Impact on Respiratory Function, Complications · NA · not yet recruiting
- NCT06766721 — Ultrasound for Diagnosing Costochondral Joint Separation · NA · not yet recruiting
- NCT07228598 — Biofilm on Chest Drains After Thoracic Surgery: Clinical Impact and Antibiotic Resistance · recruiting
- NCT06663020 — Impact of Smoking Cessation Duration on Postoperative Complications in Lung Cancer Surgery · active not recruiting
- NCT07100509 — Major Vascular Injuries in Elective Thoracic Surgery: A 10-Year Single-Center Experience · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06816758 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Caner İşevi, MD
- Last refreshed: 21 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06816758.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing